P

Pharmala Biotech Holdings
MDMA

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
CA$14.48M
EV
-
Shares Outstanding
103.45M
Beta
1.38

Wall Street View

Analyst Rating
NOT_AVAILABLE
Analyst Target Price
-
P/E undefinedE
-
P/Revenue undefinedE
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Pharmala Biotech Holdings Inc.

gainify

P

Pharmala Biotech Holdings Inc.

MDMA

Pharmala Biotech Holdings Inc., doing business as PharmAla, engages in the manufacture and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community. It offers its MDMA drug active pharmaceutical ingredient under the LaNeo brand na...

Sector

Healthcare

Industry

Biotechnology

CEO

Kadysh, Nicholas

Employees

IPO Date

2022-01-11

Headquarters

1055 West Georgia Street P.O. Box 11117, Vancouver, British Columbia, V6E 4N7, Canada

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved